The Living Donor Liver Transplant program at NewYork-Presbyterian/Columbia is one of the largest living donor liver programs in North America. Every year we perform more deceased-donor and living donor liver transplants, in both adults and children, than any program in New York.
Patients who come to our program have a significantly higher chance of receiving a liver transplant within one year than if they go to any other hospital in the northeast. According to data from the Scientific Registry of Transplant Recipients (SRTR), the organization that collects, analyzes, and disseminates data about organ transplant outcomes in the United States, patients at NYP/Columbia are 50% less likely to die while on the waitlist compared to patients at all other liver transplant centers in the region.
Table: This data shows the rates of transplant (deceased donor and living donor combined), and percent of patients still on the waitlist after 1 year, among patients at highest need of transplant -- those with MELD scores of 15-24. Data for other patient populations and further detail is available at SRTR.org.
Unique strengths of the NYP/Columbia Living Donor Liver Transplant Program
- Full time living donor liver transplant coordinator
- Specialized donor nurses who are trained in donor care and are sensitive to the special needs of donors
- Donor Mentoring Program which provides emotional support and advice from people who have donated
- Laparoscopic approach to all donation which enables smaller incisions and faster recovery
- Fully laparoscopic surgery for donations to children
- Outcomes that well exceed the national outcomes and expected outcomes for liver transplantation
- Active participation in the NIH national trial in understanding outcomes of donors and recipients of live donor liver transplantation
- Follow up of donors for years after donation
Jean C. Emond, MD, Chief of Transplantation and Executive Director of the Transplant Initiative, was a member of the team that pioneered the development of living donor liver transplantation, which is now considered one of the most important advances in the treatment of severe liver disease. Approximately 15-20% of the center's transplant patients currently receive a liver from a living donor. Dr. Benjamin Samstein has directed the living donor transplant program since 2008; since 2009, our program has performed fully laparoscopic donation for all pediatric liver donor liver transplants.
While great results are critical, we view caring for the whole donor as central to our mission. Thus we offer specialized nursing, nutritional support, smoking cessation, weight loss and pain management.